Variation in immunoreactive trypsinogen concentrations among michigan newborns and implications for cystic fibrosis newborn screening

Pediatric Pulmonology - Tập 46 Số 2 - Trang 125-130 - 2011
Steven J. Korzeniewski1, William I. Young1, Harry C. Hawkins1, Kevin Cavanagh1, Samya Z. Nasr2, Carrie Langbo1, Kelly R. TenEyck1, Scott D. Grosse3, Mary Kleyn1, Violanda Grigorescu1
1Michigan Department of Community Health, Lansing, Michigan
2University of Michigan, Ann Arbor, Michigan
3Centers for Disease Control and Prevention, Atlanta, Georgia

Tóm tắt

AbstractObjectiveTo investigate variation in immunoreactive trypsinogen (IRT) concentrations by race, sex, birth weight, and gestational age and their implications for the use of percentile‐based cutoffs for cystic fibrosis (CF) newborn screening (NBS) programs.Patients and MethodsThis cross‐sectional population‐based study of resident infants screened in Michigan investigates associations between demographic and perinatal variables and IRT concentrations after controlling for covariates. This study also analyzed how 96th and 99.8th IRT concentration percentiles values calculated by Michigan NBS vary by demographic and perinatal factors. Characteristics of infants having high (≥99.8th percentile) IRT concentrations and negative DNA tests are also explored.ResultsIRT mean concentrations and percentiles vary significantly by race, birth weight, gestational age, and to a lesser degree by sex. The greatest variation in mean IRT concentrations was observed among racial categories; black infants had an adjusted mean concentration of 36 ng/ml and Asian/Pacific Islander infants had a mean concentration of 25 ng/ml compared to an average concentration of 28 ng/ml in white infants and infants of other races.ConclusionsVariation in IRT concentrations resulted in the over‐representation of certain groups referred for secondary testing, particularly referrals for sweat testing based on very high (≥99.8th percentile) concentrations alone, which is no longer recommended in Michigan. Further research may be warranted to evaluate initial IRT cutoffs used for CF NBS. Pediatr. Pulmonol. 2011; 46:125–130. © 2011 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

Welsh MJ, 2001, The metabolic and molecular basis of inherited disease, 5121

10.1016/S0140-6736(79)90825-0

Grosse SD, 2004, Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs, MMWR Recomm Rep, 53, 1

10.1016/j.jpeds.2006.04.059

10.1542/peds.2005-2633I

10.1007/s10545-005-0067-0

10.1542/peds.2008-1681

10.1002/ppul.20824

10.1542/peds.99.6.819

Herson VC, 1999, Elevated immunoreactive trypsinogen (IRT) in premature infants, Pediatric Pulmonol, 28, 214A

10.1002/ppul.1950060111

10.1542/peds.2004-0275

10.1159/000020887

10.2165/00148365-200504040-00006

10.1016/j.jpeds.2005.08.004

10.1542/peds.113.6.1573

10.1542/peds.2006-1415

10.1542/peds.85.6.1001